Harrow (HROW) Interest & Investment Income (2010 - 2014)
Harrow (HROW) posted Interest & Investment Income of $5955.0 for Q4 2014, down 20.62% on a QoQ basis from $7502.0 in Q3 2014, and down 47.33% year-over-year from $11307.0 in Q4 2013.
Analysis
Harrow (HROW) Interest & Investment Income (2010 - 2014) Analysis & Trends
Harrow has reported Interest & Investment Income for 4 years, with the latest figure at $5955.0 in Q4 2014.
- On a quarterly basis, Interest & Investment Income fell 47.33% year-over-year to $5955.0 in Q4 2014; TTM through Dec 2014 was $32446.0, a 25.85% decrease from a year earlier, with the FY2014 full-year figure at $32446.0, down 25.85% from the prior year.
- Interest & Investment Income was $5955.0 for Q4 2014 at Harrow, down from $7502.0 in the prior quarter.
- The five-year high for Interest & Investment Income was $12940.0 in Q2 2013, with the low at $29.0 in Q4 2010.
- Average Interest & Investment Income over 4 years is $6570.7, with a median of $6511.5 recorded in 2013.
- The sharpest annual moves came in 2013 and 2014: Interest & Investment Income surged 194.72% in 2013, then plunged 47.33% in 2014.
- Over 4 years, Interest & Investment Income stood at $29.0 in 2010, then jumped by 19227.59% to $5605.0 in 2012, then jumped by 101.73% to $11307.0 in 2013, then slumped by 47.33% to $5955.0 in 2014.
- The last three Interest & Investment Income figures came in at $5955.0 (Q4 2014), $7502.0 (Q3 2014), and $8680.0 (Q2 2014), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 642.70 Bn | 621.95 Bn | 17.26 Bn | 219.00 Mn |
| 2 | AbbVie | 440.80 Bn | 434.23 Bn | 12.70 Bn | -679.00 Mn |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 266.37 Bn | 258.68 Bn | 11.24 Bn | - |
| 5 | Pfizer | 158.89 Bn | 147.19 Bn | 10.94 Bn | - |
| 6 | Sanofi | 52.43 Bn | 45.05 Bn | 10.79 Bn | 89.50 Mn |
| 7 | Revolution Medicines | 44.38 Bn | 44.38 Bn | - | 35.58 Mn |
| 8 | Incyte | 25.28 Bn | 20.74 Bn | 1.57 Bn | 38.12 Mn |
| 9 | United Therapeutics | 21.46 Bn | 18.80 Bn | 683.80 Mn | 31.50 Mn |
| 10 | Harrow | 1.41 Bn | 1.32 Bn | 50.36 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2014 | 5,955.00 |
| Sep 30, 2014 | 7,502.00 |
| Jun 30, 2014 | 8,680.00 |
| Mar 31, 2014 | 10,309.00 |
| Dec 31, 2013 | 11,307.00 |
| Sep 30, 2013 | 12,440.00 |
| Jun 30, 2013 | 12,940.00 |
| Mar 31, 2013 | 7,068.00 |
| Dec 31, 2012 | 5,605.00 |
| Sep 30, 2012 | 4,221.00 |
| Jun 30, 2012 | 5,584.00 |
| Dec 31, 2010 | 29.00 |
| Sep 30, 2010 | 215.00 |
| Jun 30, 2010 | 135.00 |